Macular degeneration (also called age-related macular degeneration or AMD) is a group of degenerative diseases of the retina – the light-sensitive tissue at the back of the eye.
The condition affects the specific part of the retina called the macula, which is responsible for central and fine-detail vision, causing people to lose the ability to distinguish faces, read, drive and see fine detail.
Macular degeneration can be classified into wet and dry forms. Most people with macular degeneration have the dry form.
Many people are not aware that they have macular degeneration until the disease is in the advanced stages. This is because the condition is painless and often progresses slowly. In addition, the healthy eye can compensate for the affected eye, masking vision loss. Early diagnosis and treatment offer the best hope of minimising damage.
Anyone can get macular degeneration, but some people may be at higher risk than others. Risk factors include:
One in seven Australians over the age of fifty has some evidence of macular degeneration, so it’s probably much more common than you realise.
While anyone can develop macular degeneration, research shows that you have a higher risk if you smoke or have a family history of macular degeneration.
It’s extremely important that you get your eyes checked regularly, particularly if you are in a high-risk group.
Regular eye checks after the age of 50 are important. If you have difficulty reading with your glasses, distinguishing faces, or start to see dark or empty patches in your central vision, get your eyes checked immediately.
There are also simple home tests that can indicate if you have any visual changes worth investigating, such as noticing distortion in door frames and tiles.
Prescription glasses can bend light to help it focus on the retina, but they can’t correct any damage in the retina itself.
The forms of macular degeneration that affect younger people are very rare and usually caused by a specific gene defect. The most common form is Stargardt’s Disease, which may develop from 10 years of age (although vision loss may not occur until in your twenties or thirties).
Knowing your family history in relation to eye diseases is extremely helpful.
The advanced stage of macular degeneration can be divided into two types:
For a full list of references, visit the macular degeneration FAQ page.
Complete the form below and we will send you more information about laser eye surgery. Fields marked with an asterisk (*) are mandatory.
IMPORTANT: If you are concerned about your eyes and require an urgent consultation, DO NOT use this form. Please call one of our clinics during office hours or contact your nearest emergency department instead.
Do NOT use this form in an emergency – contact one of our clinics or your nearest hospital emergency department instead.
Some services may not be performed by your preferred doctor or at your preferred clinic. We will confirm this with you before making an appointment.
Everyone should have their eyes checked on a regular basis by an optometrist, regardless of whether you require glasses to see. Your optometrist will check your vision and also look for signs of any other eye disease. This is particularly important for conditions such as macular degeneration, where there may not be any noticeable visual abnormalities until late in the disease course. If there are any abnormal signs or you are in a high-risk group (e.g. you smoke, have diabetes or a family history), your optometrist may recommend further tests to examine the retina and can refer you to a retinal specialist.
If you have difficulty reading, distinguishing faces, or start to see dark or empty patches in your central vision, have your eyes checked immediately.
You can perform some simple screening tests for macular degeneration at home. For those over the age of 50, look at a straight edge (e.g. of a door or window) one eye at a time to see if there are any ‘bumps’ or missing parts to the line. If there are, have your eyes checked immediately.
An Amsler Grid may be recommended for people at high risk of developing macular degeneration. Named after Swiss ophthalmologist Marc Amsler, this grid contains a series of horizontal and vertical lines with a dot in the middle. If the lines appear wavy or any are missing, have your eyes checked immediately.
This test (sometimes called retinal photography or eye angiography) uses a fluorescent dye to show any blockages or leaks in the blood vessels supplying the retina. The dye is usually injected into a vein in your arm and flows through the blood system to the retinal blood vessels. Your ophthalmologist will use a special camera to take photographs. Please note that your vision will be blurred for up to 4–6 hours after the test, as your pupil will be dilated using eye drops.
Optical coherence tomography (OCT) is a non-invasive test that captures detailed images of the retina. The scan allows the ophthalmologist to identify areas of retinal thinning, thickening, or swelling caused by fluid build-up and leaky blood vessels. Your pupils will be dilated for this test and the procedure takes less than 10 minutes. As the OCT scanner is a kind of camera, it does not need to touch your eyes.
There is no cure for wet macular degeneration, although some treatments can slow or stop progression of the disease and vision can be maintained (or even improved) for many people.1
The benefits of early treatment are:
Eye injections are the gold standard treatment for wet macular degeneration. They can be used to stop abnormal blood vessels from leaking and dry up the abnormal macular fluid (oedema). Repeated injections and regular monitoring can prevent further vision loss in 95% of sufferers.2 Vision is significantly improved in up to 40% of those treated.3 Most patients receiving eye injections will require regular, lifelong treatments to maintain their vision.
Vascular Endothelial Growth Factor (VEGF) is a protein secreted by oxygen-deprived cells. Low levels of VEGF are normal; however when there are high levels of this protein, abnormal blood vessels will grow. Anti-VEGF drugs block the protein and the corresponding abnormal blood vessel growth – they are given as eye injections. These drugs are used in the treatment of macular degeneration and diabetic retinopathy.
Anaesthetic drops are used to numb the eye, and the injection is given via a tiny needle from the side – you won’t be able to see the needle coming towards your eye. You may feel slight pressure, but there won’t be any pain.
Photodynamic therapy is occasionally used for a small number of patients who have a specific type of AMD. A special dye, known as a photosensitiser, is injected into an arm vein and flows through the blood system to the retinal blood vessels at the back of the eye. A cold laser is then used to activate the dye, with the resultant photochemical effect shrinking and sealing abnormal blood vessels. Many people will need to be treated about every 3–4 months.
Eye injections may be used in conjunction with photodynamic therapy.
Unfortunately, there is no approved treatment for patients with the dry form.
Research studies investigating disease progression and potential therapies, some of which involve Vision Eye Institute specialists, are currently ongoing.
Smokers are three times more likely to develop macular degeneration4 (in addition to a number of other serious health-related issues), so now is the time to quit.
Research has shown eating foods rich in carotenoids are particularly beneficial.5 These include dark green leafy vegetables (e.g. spinach and kale) and coloured vegetables (particularly gold-coloured ones, e.g. corn, yellow capsicum, sweet potato). Foods rich in vitamin C, omega-3 fatty acids (e.g. oily fish such as salmon) and zinc are also good for eye health.
1. Vision Australia. Age related macular degeneration [Internet]. Australia: Vision Australia; [date unknown] [cited 2021 Jan 27]. Available from: https://www.visionaustralia.org/information/eye-conditions/Aged-Related-Macular-Degeneration
2. Baumal. Wet age-related macular degeneration: treatment advances to reduce the injection burden. Am J Manag Care. 2020 May;26(5 Suppl):S103-S111. doi: 10.37765/ajmc.2020.43435.
3. Haddrill. Macular degeneration treatment, FDA approved [Internet]. Irving (Texas): All About Vision; [date unknown] [updated 2018; cited 2021 Jan 27]. Available from: https://www.allaboutvision.com/conditions/amd-treatments.htm
4. Macular Disease Foundation Australia. Risk factors [Internet]. Sydney (NSW): Macular Disease Foundation Australia; [date unknown] [cited 2021 Jan 27]. Available from: https://www.mdfoundation.com.au/content/risk-factors-macular-degeneration
5. Wu et al. Intakes of lutein, zeaxanthin, and other carotenoids and age-related macular degeneration during 2 decades of prospective follow-up. JAMA Ophthalmol. 2015 Dec; 133(12): 1415–1424. doi: 10.1001/jamaophthalmol.2015.3590
MBBS BSc(Hons) FRANZCO
MBBS FRANZCO
BSc MBBS MMed(OphthSc) MMed(ClinEpi)(Hons) Genomics(PGcert) FRCOphth FRANZCO
MBBS MPH FRANZCO
MBBS FRACS FRANZCO
MBBS MD FRCOphth FRANZCO
BMBCh PhD FRCOphth FRANZCO
MBBS FRACS FRCOphth FRANZCO
MBBS(Hons) MMed FRANZCO
MBBS(Hons) MMed MPH FRANZCO
MBBCh BAO PhD FRCOphth FRANZCO
MBBCh, PhD, FRCOphth, FRANZCO
The information on this page is general in nature. All medical and surgical procedures have potential benefits and risks. Consult your ophthalmologist for specific medical advice.
Date last reviewed: 2023-11-10 | Date for next review: 2025-11-10
